SUPN
Supernus Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$43.53
−1.00%Leverage
- Debt / equity
- 0.04x
- Net debt / equity
- -0.14x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -2.53x
- Net debt / EBITDA
- 8.81x
Liquidity & coverage
- Current ratio
- 2.08x
- Quick ratio
- 1.84x
- Cash ratio
- 1.07x
- Interest coverage
- -48.30x
- EBITDA / interest
- -6.85x
- Working capital
- $376.1M
Cash & dividend
- FCF / debt
- 0.47x
- Cash flow / debt
- 0.50x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026